| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.400 | None | 0.948 | 21 | 0 | 1983 | 2020 | ||||||||
|
CEA cell adhesion molecule 5 | 0.420 | 0.846 | 4.2E-10 |
|
group | 0.100 | None | 0.980 | 2 | 0 | 1983 | 2020 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
group | 0.100 | None | 0.971 | 2 | 0 | 1983 | 2018 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.700 | None | 0.975 | 18 | 0 | 1986 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
group | 0.400 | None | 0.973 | 15 | 0 | 1986 | 2020 | ||||||||
|
gastrin | 0.485 | 0.808 | 2.7E-03 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 1986 | 2018 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
group | 0.400 | None | 0.966 | 1 | 0 | 1986 | 2018 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
group | 0.100 | None | 1.000 | 2 | 0 | 1987 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
group | 0.100 | None | 0.923 | 2 | 0 | 1987 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.400 | None | 0.971 | 47 | 0 | 1988 | 2020 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.400 | None | 1.000 | 5 | 0 | 1988 | 2018 | ||||||||
|
CEA cell adhesion molecule 6 | 0.561 | 0.731 | 1.2E-06 |
|
group | 0.070 | None | 1.000 | 2 | 0 | 1988 | 2017 | ||||||||
|
epithelial cell adhesion molecule | 0.451 | 0.885 | 1.3E-07 |
|
group | 0.100 | None | 1.000 | 1 | 0 | 1989 | 2019 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.400 | None | 1.000 | 5 | 0 | 1990 | 2019 | ||||||||
|
trefoil factor 1 | 0.529 | 0.769 | 8.9E-04 |
|
group | 0.100 | None | 1.000 | 2 | 0 | 1990 | 2019 | ||||||||
|
presenilin 2 | 0.550 | 0.654 | 5.4E-04 |
|
group | 0.020 | None | 1.000 | 1 | 0 | 1990 | 2008 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.400 | None | 1.000 | 3 | 0 | 1991 | 2017 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
group | 0.400 | None | 0.914 | 3 | 0 | 1991 | 2020 | ||||||||
|
Raf-1 proto-oncogene, serine/threonine kinase | 0.418 | 0.885 | 0.85 |
|
group | 0.070 | None | 1.000 | 2 | 0 | 1991 | 2016 | ||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
group | 0.390 | None | 1.000 | 2 | 0 | 1991 | 2018 | ||||||||
|
serpin family E member 1 | 0.359 | 0.885 | 4.4E-02 |
|
group | 0.100 | None | 1.000 | 1 | 0 | 1991 | 2017 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.400 | None | 0.982 | 4 | 0 | 1992 | 2019 | ||||||||
|
thymidylate synthetase | 0.425 | 0.846 | 0.72 |
|
group | 0.100 | None | 0.917 | 3 | 0 | 1992 | 2017 | ||||||||
|
proliferating cell nuclear antigen | 0.382 | 0.846 | 0.98 |
|
group | 0.400 | None | 0.933 | 1 | 0 | 1992 | 2019 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
group | 0.100 | None | 0.971 | 1 | 0 | 1992 | 2019 |